|1.||Yamamoto, Noriyuki: 2 articles (03/2015 - 10/2014)|
|2.||Yarimizu, Junko: 2 articles (03/2015 - 10/2014)|
|3.||Yamazaki, Mayako: 2 articles (03/2015 - 10/2014)|
|4.||Harada, Katsuya: 2 articles (03/2015 - 10/2014)|
|5.||Okabe, Mayuko: 2 articles (03/2015 - 10/2014)|
|6.||Collier, D A: 2 articles (05/2001 - 06/2000)|
|7.||Barragán-Iglesias, Paulino: 1 article (10/2015)|
|8.||Velázquez-Lagunas, Isabel: 1 article (10/2015)|
|9.||Salinas-Abarca, Ana Belen: 1 article (10/2015)|
|10.||Avila-Rojas, Sabino Hazael: 1 article (10/2015)|
|1.||Schizophrenia (Dementia Praecox)
10/01/2014 - "These results collectively suggest that ASP5736 is a novel and potent 5-HT5A receptor antagonist that not only ameliorates positive-like symptoms but also cognitive impairments in animal models of schizophrenia, without adverse effects. "
10/01/2014 - "ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia."
07/01/2004 - "Family-based association studies between 5-HT5A receptor gene and schizophrenia."
03/01/2015 - "We recently reported that the selective 5-HT5A receptor antagonist ASP5736 ameliorated cognitive impairment in several animal models of schizophrenia. "
08/01/2004 - "We also demonstrated a positive association between schizophrenia and a 5-HT5A receptor polymorphism, Pro15Ser, that may have role in cell differentiation in the brain."
03/01/2015 - "Given that areas of the brain with high levels of 5-HT5A receptor expression, such as the hippocampus and cerebral cortex, have important functions in cognition and memory, we evaluated the chemically diverse, potent and brain-penetrating 5-HT5A receptor antagonists ASP5736, AS2030680, and AS2674723 in rodent models of cognitive dysfunction associated with dementia. "
03/01/2015 - "These results indicate that the 5-HT5A receptor is involved in learning and memory and that treatment with 5-HT5A receptor antagonists might be broadly effective for cognitive impairment associated with not only schizophrenia but also dementia. "
|3.||Mood Disorders (Mood Disorder)
05/04/2001 - "In the present study, genetic variation of the 5-HT5A receptor was analyzed in patients affected by affective disorders and healthy controls. "
05/04/2001 - "Our results suggest that the polymorphisms analyzed in the 5-HT5A receptor gene do not play a major role in the pathogenesis of affective disorders."
06/26/2000 - "We conclude that allelic variation in the human 5-HT5A receptor gene may be involved in susceptibility to schizophrenia and affective disorders but not in determining response to clozapine."
|4.||Ganglion Cysts (Ganglion)
|7.||Adenylate Cyclase (Adenylyl Cyclase)
|8.||CQ 32085 (mesulergine)